Ernest Shingyan Wong
Keine laufenden Positionen mehr
Karriereverlauf von Ernest Shingyan Wong
Ehemalige bekannte Positionen von Ernest Shingyan Wong
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NERVGEN PHARMA CORP. | Direktor/Vorstandsmitglied | 06.06.2018 | 27.11.2019 |
| Vorstandsvorsitzender | 18.06.2018 | 27.11.2019 | |
| Präsident | 18.06.2018 | 27.11.2019 | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Corporate Officer/Principal | 01.01.2016 | 01.10.2018 |
| AGENUS INC. | Corporate Officer/Principal | 01.05.2015 | 01.12.2015 |
Life Molecular Imaging Ltd.
 Life Molecular Imaging Ltd. Medical DistributorsDistribution Services Part of Old AMGL Interests 2 Ltd, Life Molecular Imaging Ltd. is a British company that wholesales diagnostic imaging solutions. The company is based in Warwick, UK. Life Molecular Imaging was founded in 2003. | Corporate Officer/Principal | 01.04.2013 | 01.04.2015 |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 17.01.2011 | - |
Ausbildung von Ernest Shingyan Wong
| University of British Columbia | Doctorate Degree |
| The University of Colorado | Masters Business Admin |
| Simon Fraser University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Kanada | 4 |
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NERVGEN PHARMA CORP. | Health Technology |
| AGENUS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
Life Molecular Imaging Ltd.
Life Molecular Imaging Ltd. Medical DistributorsDistribution Services Part of Old AMGL Interests 2 Ltd, Life Molecular Imaging Ltd. is a British company that wholesales diagnostic imaging solutions. The company is based in Warwick, UK. Life Molecular Imaging was founded in 2003. | Distribution Services |
- Börse
- Insiders
- Ernest Shingyan Wong
- Erfahrung
